TXNIP and Parkinson disease: Generated midbrain organoids carrying the LRRK2G2019S mutation, recapitulating the pathological features of patients with LRRK2‐associated sporadic PD, and revealed the functional role for TXNIP in the 3D environment of LRRK2‐associated PD.